FY 2014 GDUFA Regulatory Science Funding Announcements
As part of the Generic Drug User Fee Amendments (GDUFA) of 2012, The Food and Drug Administration held a public meeting on June 21, 2013 to seek input from a variety of stakeholders in developing the FY 2014 Regulatory Science Initiatives.
The resulting FY 2014 research priorities are: post-market evaluation of generic drugs, equivalence of complex products, equivalence of locally-acting products, therapeutic equivalence evaluation and standards, and computational and analytical tools. Scientific research opportunities funded through the GDUFA Regulatory Science Research Program are announced on Grants.gov and FedBizOpps.gov.
As of June 20, 2014, all FY 2014 GDUFA Regulatory Science funding application periods have closed. Please check the Generic Drug User Fee Amendments of 2012 page for FY 2015 opportunities when they become available.